Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (115)	9/12/2006 3:30:30 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 507

Ian, I agree...new tech. often takes a while to develop...look at Haloid Corporation...near being bankrupt when someone came up with the idea of changing the name to something that better described their product....thus, today we have a company called ..Xerox Corporation. As for the biotech area...look at how successful Celgene has become with a drug given up for Davey Jones' locker. But with Exubera, I can't understand all the delays when last fall we were told about the huge build-up of inventory in the Indiana facility....and now nothing but silence from the two companies... I hope I'm wrong on this issue...but smarter people than I have for some reason driven this stock to levels below when it got FDA approval...where there is smoke..often there is fire!!